Literature DB >> 181379

Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Structural requirements for effects of vasoactive intestinal peptide and secretin on cellular adenosine 3':5'-monophosphate.

P Robberecht, T P Conlon, J D Gardner.   

Abstract

Secretin and vasoactive intestinal peptide (VIP), but not glucagon, stimulate accumulation of cyclic AMP in dispersed guinea pig pancreatic acinar cells. Secretin stimulated cellular accumulation of cyclic AMP by interacting with a single class of high affinity receptors. On the other hand, the dose-response curve for VIP-stimulated cellular cyclic AMP was biphasic and reflected interaction of this peptide with two classes of receptors. Results obtained with synthetic fragments of VIP and secretin indicate that the receptor having a high affinity for VIP has a low affinity for secretin, interacts with, but does not distinguish among, secretin, secretin 5-27 and [6-tyrosine] secretin or among secretin 14-27, VIP 14-28, VIP 15-28, and increases cellular cyclic AMP when occupied by VIP, but not when occupied by secretin, [6-tyrosine] secretin, or secretin 1-14. The receptor having a low affinity for VIP has a high affinity for secretin, interacts with and distinguishes among secretin, secretin 5-27, and [6-tyrosine] secretin, interacts with secretin 14-27 but not with VIP 14-28 or VIP 15-28, and increases cellular cyclic AMP when occupied by VIP, secretin, [6-tyrosine] secretin, or secretin 1-14.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181379

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Biochemical basis of action of gastrointestinal hormones.

Authors:  J D Gardner
Journal:  World J Surg       Date:  1979-08-31       Impact factor: 3.352

2.  Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells.

Authors:  R T Jensen; T Moody; C Pert; J E Rivier; J D Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

3.  Regulation of amylase release from dispersed pancreatic acinar cells.

Authors:  J D Gardner; M J Jackson
Journal:  J Physiol       Date:  1977-09       Impact factor: 5.182

4.  Effect of vasoactive intestinal peptide (VIP) and other neuropeptides on cAMP accumulation in brain slices [proceedings].

Authors:  S Bloom; L L Iversen; M Quik
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

5.  Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture.

Authors:  M Laburthe; M Rousset; C Boissard; G Chevalier; A Zweibaum; G Rosselin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

6.  Action of cholecystokinin and cholinergic agents on membrane-bound calcium in dispersed pancreatic acinar cells.

Authors:  H T Shelby; L P Gross; P Lichty; J D Gardner
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

7.  Effect of vasoactive intestinal peptide on cyclic adenosine monophosphate production in enterocytes isolated from human duodenal biopsy specimens.

Authors:  J A Smith; M Griffin; S E Mireylees; R G Long
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

8.  Vasoactive intestinal polypeptide: specific binding to rat brain membranes.

Authors:  D P Taylor; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

9.  Characterization of the VIP- and secretin-stimulated adenylate cyclase system from human lung.

Authors:  G Taton; M Delhaye; J C Camus; P de Neef; P Chatelain; P Robberecht; J Christophe
Journal:  Pflugers Arch       Date:  1981-09       Impact factor: 3.657

10.  Secretin and VIP-stimulated adenylate cyclase from rat heart. II. Impairment in spontaneous hypertension.

Authors:  P Chatelain; P Robberecht; P De Neef; J C Camus; D Heuse; J Christophe
Journal:  Pflugers Arch       Date:  1980-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.